Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FPQZ8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,064
Award facts
- Contract value 100% obligated
- $15,063.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which provides a comprehensive framework for pharmaceutical product distribution to military health facilities nationwide.
The delivery order falls within the scope of DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, supporting the Department of Defense healthcare system through the DLA's procurement operations. EXPAREL is a liposomal bupivacaine injectable anesthetic used in surgical and pain management applications, representing the type of specialized pharmaceutical product covered under the company's IDC. As a single-award contract vehicle, the IDC enables the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support military medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FPQZ8?
SPE2DB25FPQZ8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FPQZ8 worth?
The government has obligated $15,064 on SPE2DB25FPQZ8.
Is contract SPE2DB25FPQZ8 an order under another contract?
Yes. SPE2DB25FPQZ8 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPQZ8 competed?
The extent of competition for SPE2DB25FPQZ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award